Yahoo Finance

Estimated Discount To Fair Value: 48.5%

ALTEOGEN is currently trading at ₩439,500, significantly below its estimated fair value of ₩852,939.21. The company's revenue is expected to grow at an impressive 84.2% annually, surpassing the Korean market average of 8.7%. Additionally, ALTEOGEN's earnings are projected to increase by 140.63% per year and it is anticipated to become profitable within three years. Recent private placements may enhance financial flexibility but come with a mandatory one-year lockup period for investors.

• The growth report we've compiled suggests that ALTEOGEN's future prospects could be on the up.

• Click here and access our complete balance sheet health report to understand the dynamics of ALTEOGEN.

EQT

Overview: EQT AB (publ) is a global private equity and venture capital firm that specializes in private capital and real asset segments, with a market cap of approximately SEK368.69 billion.

Operations: The company's revenue is primarily derived from its Private Capital segment at €1.36 billion and Real Assets segment at €951.90 million, with an additional contribution of €41.50 million from the Central segment.

Estimated Discount To Fair Value: 21.1%

EQT's recent financials reveal a robust performance, with net income soaring to EUR 776 million from EUR 168 million. The stock is trading over 20% below its fair value estimate of SEK394.94, suggesting it may be undervalued based on cash flows. Despite insider selling and a dividend not well-covered by earnings, EQT's earnings are forecasted to grow significantly at 27.8% annually, outpacing the Swedish market average of 9.3%.

• According our earnings growth report, there's an indication that EQT might be ready to expand.

• Navigate through the intricacies of EQT with our comprehensive financial health report here.

Seize The Opportunity

• Click this link to deep-dive into the 496 companies within our Undervalued Global Stocks Based On Cash Flows screener.

• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.

• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include DB:R3NK KOSDAQ:A196170 and OM:EQT.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com